skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Humans remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Clinical determinants of calcineurin inhibitor disposition: a mechanistic review
Clinical determinants of calcineurin inhibitor disposition: a mechanistic review
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical determinants of calcineurin inhibitor disposition: a mechanistic review

Vanhove, Thomas ; Annaert, Pieter ; Kuypers, Dirk R. J.

Drug metabolism reviews, 2016-01, Vol.48 (1), p.88-112 [Periódico revisado por pares]

England: Taylor & Francis

Texto completo disponível

Citações Citado por
2
Pharmacogenomic implications of the differential distribution of CYP3A5 metabolic phenotypes among Latin American populations
Pharmacogenomic implications of the differential distribution of CYP3A5 metabolic phenotypes among Latin American populations
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pharmacogenomic implications of the differential distribution of CYP3A5 metabolic phenotypes among Latin American populations

Suarez-Kurtz, Guilherme ; Struchiner, Claudio José

Pharmacogenomics, 2024-03, Vol.25 (4), p.187-195 [Periódico revisado por pares]

England: Future Medicine Ltd

Texto completo disponível

Citações Citado por
3
Impact of CYP3A5 phenotype on tacrolimus time in therapeutic range and clinical outcomes in pediatric renal and heart transplant recipients
Impact of CYP3A5 phenotype on tacrolimus time in therapeutic range and clinical outcomes in pediatric renal and heart transplant recipients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impact of CYP3A5 phenotype on tacrolimus time in therapeutic range and clinical outcomes in pediatric renal and heart transplant recipients

Leino, Abbie D. ; Park, Jeong M. ; Pasternak, Amy L.

Pharmacotherapy, 2021-08, Vol.41 (8), p.649-657 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
4
Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit
Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit
Material Type:
Artigo 		Adicionar ao Meu Espaço

Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit

Jonge, Hylke ; Vanhove, Thomas ; Loor, Henriëtte ; Verbeke, Kristin ; Kuypers, Dirk R. J.

British journal of clinical pharmacology, 2015-09, Vol.80 (3), p.548-559 [Periódico revisado por pares]

England: John Wiley & Sons, Ltd

Texto completo disponível

Citações Citado por
5
Physiologically-based pharmacokinetic modeling-guided rational combination of tacrolimus and voriconazole in patients with different CYP3A5 and CYP2C19 alleles
Physiologically-based pharmacokinetic modeling-guided rational combination of tacrolimus and voriconazole in patients with different CYP3A5 and CYP2C19 alleles
Material Type:
Artigo 		Adicionar ao Meu Espaço

Physiologically-based pharmacokinetic modeling-guided rational combination of tacrolimus and voriconazole in patients with different CYP3A5 and CYP2C19 alleles

Gong, Fei ; Hu, Huihui ; Ouyang, Ying ; Liao, Zheng-Zheng ; Kong, Ying ; Hu, Jin-Fang ; He, Hua ; Zhou, Ying

Toxicology and applied pharmacology, 2023-05, Vol.466, p.116475-116475, Article 116475 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
6
Population pharmacokinetics and pharmacogenetics of apatinib in adult cancer patients
Population pharmacokinetics and pharmacogenetics of apatinib in adult cancer patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Population pharmacokinetics and pharmacogenetics of apatinib in adult cancer patients

Yang, Xin‐Mei ; Ye, Pan‐Pan ; Liu, Xiao‐Lin ; Guo, Zi‐Xuan ; Kan, Min ; Li, Qian ; Song, Lin‐Lin ; Liu, Hong‐Ying ; Chen, Ke‐Guang ; Shi, Jin‐Yi ; Zhang, Ye‐Hui ; Li, Ya ; Zhao, Fu‐Rong ; Anker, John ; Li, Yan ; Zhao, Wei

British journal of clinical pharmacology, 2023-06, Vol.89 (6), p.1862-1872 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
7
CYP3A7, CYP3A4, and CYP3A5 genetic polymorphisms in recipients rather than donors influence tacrolimus concentrations in the early stages after liver transplantation
CYP3A7, CYP3A4, and CYP3A5 genetic polymorphisms in recipients rather than donors influence tacrolimus concentrations in the early stages after liver transplantation
Material Type:
Artigo 		Adicionar ao Meu Espaço

CYP3A7, CYP3A4, and CYP3A5 genetic polymorphisms in recipients rather than donors influence tacrolimus concentrations in the early stages after liver transplantation

Dong, Yue ; Xu, Qinxia ; Li, Ruidong ; Tao, Yifeng ; Zhang, Quanbao ; Li, Jianhua ; Ma, Zhenyu ; Shen, Conghuan ; Zhong, Mingkang ; Wang, Zhengxin ; Qiu, Xiaoyan

Gene, 2022-01, Vol.809, p.146007-146007, Article 146007 [Periódico revisado por pares]

Netherlands: Elsevier B.V

Texto completo disponível

Citações Citado por
8
The impact of CYP3A53 on oral quetiapine: A population pharmacokinetic model in Chinese bipolar disorder patients
The impact of CYP3A53 on oral quetiapine: A population pharmacokinetic model in Chinese bipolar disorder patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

The impact of CYP3A53 on oral quetiapine: A population pharmacokinetic model in Chinese bipolar disorder patients

Lin, Meihua ; Zhang, Yu ; Lv, Duo ; Xu, Nana ; Yang, Xi ; Liu, Xueling ; Yan, Caixia ; Wu, Meijia ; Kai, Jiejing ; Hu, Shaohua ; Zhao, Qingwei

Journal of affective disorders, 2024-04, Vol.351, p.309-313 [Periódico revisado por pares]

Netherlands: Elsevier B.V

Texto completo disponível

Citações Citado por
9
Composite CYP3A phenotypes influence tacrolimus dose-adjusted concentration in lung transplant recipients
Composite CYP3A phenotypes influence tacrolimus dose-adjusted concentration in lung transplant recipients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Composite CYP3A phenotypes influence tacrolimus dose-adjusted concentration in lung transplant recipients

Liu, Michelle ; Shaver, Ciara M ; Birdwell, Kelly A ; Heeney, Stephanie A ; Shaffer, Christian M ; Van Driest, Sara L

Pharmacogenetics and genomics, 2022-07, Vol.32 (5), p.209-217 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
10
Active-site differences between substrate-free and ritonavir-bound cytochrome P450 (CYP) 3A5 reveal plasticity differences between CYP3A5 and CYP3A4
Active-site differences between substrate-free and ritonavir-bound cytochrome P450 (CYP) 3A5 reveal plasticity differences between CYP3A5 and CYP3A4
Material Type:
Artigo 		Adicionar ao Meu Espaço

Active-site differences between substrate-free and ritonavir-bound cytochrome P450 (CYP) 3A5 reveal plasticity differences between CYP3A5 and CYP3A4

Hsu, Mei-Hui ; Johnson, Eric F.

The Journal of biological chemistry, 2019-05, Vol.294 (20), p.8015-8022 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (429)

Data de Publicação 

De até
Refinar
  1. Antes de2003  (10)
  2. 2003Até2007  (69)
  3. 2008Até2012  (136)
  4. 2013Até2018  (144)
  5. Após 2018  (84)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.